Fiorentino, Francesca, Beatrice Canali, Paolo Morelli, and Federica Demma. “Brentuximab Vedotin in Combination With Doxorubicin, Vinblastine and Dacarbazine for First-Line Treatment of Stage IV HL: Cost Impact on Subsequent Lines in Italy”. AboutOpen 10, no. 1 (January 16, 2023): 6–12. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/aboutopen/article/view/2486.